[CYCC] YoY Quarter Result on 31-Dec-2012 [#Q4]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
01-Apr-2013
Financial Year
2012
Quarter
31-Dec-2012 [#Q4]
Profit Trend
QoQ- -152.06%
YoY- -30.24%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Revenue 424 247 299 5 175 138 187 14.61%
PBT -3,872 -5,907 -4,026 -5,067 -3,780 -3,323 -4,489 -2.43%
Tax -498 -1,108 -452 -637 -122 -151 -152 21.85%
NP -3,374 -4,799 -3,559 -4,764 -3,658 -3,172 -4,337 -4.09%
Tax Rate - - - - - - - -
Total Cost 3,798 5,046 3,858 4,769 3,833 3,310 4,524 -2.87%
Ratio Analysis
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
NP Margin -795.75 -1,942.91 -1,190.30 -95,280.00 -2,090.29 -2,298.55 -2,319.25 -16.32%
Per Share
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
EPS -23.15 -50.11 -44.87 -149.01 -113.25 -115.84 -229.70 -31.77%
EPS Diluted -23.15 -50.11 -44.87 -149.01 -112.22 -114.43 -229.70 -31.77%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.